Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
CompletedOBSERVATIONAL
Enrollment
337
Participants
Timeline
Start Date
July 22, 2016
Primary Completion Date
February 14, 2018
Study Completion Date
February 14, 2018
Conditions
Human Immunodeficiency Virus
All Listed Sponsors
lead
Janssen-Cilag S.p.A.
INDUSTRY
NCT02926456 - Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta) | Biotech Hunter | Biotech Hunter